Trial of Psilocybin vs Escitalopram for Depression
July 27, 2021 DOI: 10.64239/pi-qt2903 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial |
|---|---|
| Intervention | Escitalopram |
| Topics | Depression Psilocybin |
| Key findings | Escitalopram was not better than placebo, but equivalent. |
Abstract
A mood disorder study published in the New England Journal of Medicine is a bullet unto itself. Use of escitalopram, not a placebo, for the comparison group—another rarity! And the results? Well, not better, but equivalent. Here comes big pharmaceutical company money.